Drawing for THERAPEUTICS AT THE CARDIORENAL CROSSROADS

USPTO serial 77232321

THERAPEUTICS AT THE CARDIORENAL CROSSROADS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUTLER, ANDREA P
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with THERAPEUTICS AT THE CARDIORENAL CROSSROADS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bingham B. Leverich, Esq.

BINGHAM B. LEVERICH, ESQ. COVINGTON & BURLING LLP1201 PENNSYLVANIA AVE NWWASHINGTON, DC 20004-2401UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
016Printed publications, namely, magazines, newsletters and booklets on the topics of cardiorenal diseases and disorders, the prevention, diagnosis and treatment of cardiorenal diseases and disorders, and dosing options of pharmaceuticals for the treatment and prevention of cardiorenal diseases and disorders; printed materials, namely, brochures, bulletins, pamphlets, flyers, reports, annual reports and booklets on the subject of cardiorenal diseases and disorders, the prevention, diagnosis and treatment of cardiorenal diseases and disorders, and dosing options of pharmaceuticals for the treatment and prevention of cardiorenal diseases and disordersACTIVE—
041Educational services, namely, conducting seminars and conferences in the field of pharmaceuticals and cardiorenal diseases and disordersACTIVE—
042Internet website providing information on clinical trials for existing and prospective pharmaceutical products; medical and scientific research services in the field of cardiorenal diseases and disorders and the prevention, diagnosis and treatment thereofACTIVE—
044Health information services, namely, providing information to patients on topics of cardiorenal diseases and disorders, the prevention, diagnosis and treatment of cardiorenal diseases and disorders, and dosing options of pharmaceuticals for the treatment and prevention of cardiorenal diseases and disorders; providing links to the websites of others featuring information about the prevention, diagnosis and treatment of cardiorenal diseases and disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 13, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 13, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 21, 2010EX3GSOU EXTENSION 3 GRANTED—
Jan 19, 2010EXT3SOU EXTENSION 3 FILED—
Jan 19, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 23, 2009EX2GSOU EXTENSION 2 GRANTED—
Jul 23, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 30, 2009EXT2SOU EXTENSION 2 FILED—
Jun 30, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 5, 2009EX1GSOU EXTENSION 1 GRANTED—
Feb 5, 2009EXT1SOU EXTENSION 1 FILED—
Feb 5, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 12, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 20, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 30, 2008NPUBNOTICE OF PUBLICATION—
Apr 15, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 15, 2008ALIEASSIGNED TO LIE—
Apr 8, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 8, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Apr 8, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 8, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 8, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 24, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2007DOCKASSIGNED TO EXAMINER—
Jul 23, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance